# TAK-935 Multiple Rising Dose Study in Healthy Participants

> **NCT02539134** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 40 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** TAK-935
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02539134
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02539134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02539134, "TAK-935 Multiple Rising Dose Study in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02539134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*